1. Home
  2. PTMN vs VXRT Comparison

PTMN vs VXRT Comparison

Compare PTMN & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTMN
  • VXRT
  • Stock Information
  • Founded
  • PTMN 2006
  • VXRT N/A
  • Country
  • PTMN United States
  • VXRT United States
  • Employees
  • PTMN N/A
  • VXRT N/A
  • Industry
  • PTMN Finance: Consumer Services
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PTMN Finance
  • VXRT Health Care
  • Exchange
  • PTMN Nasdaq
  • VXRT Nasdaq
  • Market Cap
  • PTMN 142.6M
  • VXRT 119.0M
  • IPO Year
  • PTMN N/A
  • VXRT N/A
  • Fundamental
  • Price
  • PTMN $14.08
  • VXRT $0.35
  • Analyst Decision
  • PTMN Hold
  • VXRT Strong Buy
  • Analyst Count
  • PTMN 1
  • VXRT 2
  • Target Price
  • PTMN $16.00
  • VXRT $3.00
  • AVG Volume (30 Days)
  • PTMN 54.0K
  • VXRT 1.8M
  • Earning Date
  • PTMN 05-07-2025
  • VXRT 03-20-2025
  • Dividend Yield
  • PTMN 15.46%
  • VXRT N/A
  • EPS Growth
  • PTMN N/A
  • VXRT N/A
  • EPS
  • PTMN N/A
  • VXRT N/A
  • Revenue
  • PTMN $62,432,000.00
  • VXRT $28,700,000.00
  • Revenue This Year
  • PTMN N/A
  • VXRT N/A
  • Revenue Next Year
  • PTMN $4.14
  • VXRT $48.02
  • P/E Ratio
  • PTMN N/A
  • VXRT N/A
  • Revenue Growth
  • PTMN N/A
  • VXRT 288.94
  • 52 Week Low
  • PTMN $13.90
  • VXRT $0.34
  • 52 Week High
  • PTMN $20.84
  • VXRT $1.30
  • Technical
  • Relative Strength Index (RSI)
  • PTMN 16.81
  • VXRT 25.21
  • Support Level
  • PTMN $14.30
  • VXRT $0.49
  • Resistance Level
  • PTMN $15.69
  • VXRT $0.60
  • Average True Range (ATR)
  • PTMN 0.42
  • VXRT 0.04
  • MACD
  • PTMN -0.13
  • VXRT -0.01
  • Stochastic Oscillator
  • PTMN 7.14
  • VXRT 4.69

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Share on Social Networks: